Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 13 Aug 2025 for Aldeyra Therapeutics, Inc., €98k. Read the official filing
Filing timeline
BuySaleStephen Machatha
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Stephen Machatha: trading record in brief
All filings by Stephen Machatha on record concern Aldeyra Therapeutics, Inc., in the capacity of senior executive. Between 30 March 2022 and 11 August 2025, the trades on record add up to 6 filings.
On the market, this insider has only sold: 4 sales, €257k in total. Besides market trades, the filings include 2 share grants. 2025 to date brings no purchases and 1 sale.
Most recently, on 13 August 2025, the filings show an open-market sale worth €98k in Aldeyra Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen Machatha
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
22,073 shares@ US$5.151738.0% of flowCommon StockSEC:0000950170-25-108210:0
16,041 shares@ US$4.736343.5% of flowCommon StockSEC:0000950170-24-097071:0
11,537 shares@ US$3.16420.9% of flowCommon StockSEC:0000950170-24-045113:0
18,231 shares@ US$3.406435.6% of flowCommon StockSEC:0000950170-24-030311:0
185,605 shares0Common StockSEC:0000899243-22-026344:0
64,395 shares0Common StockSEC:0000899243-22-013173:0
6 of 6 declarations
